A combination of monoclonal antibodies for detecting feline coronavirus NP protein and application thereof

By developing a monoclonal antibody combination of 3C6 and 6H9 for colloidal gold immunochromatographic detection, the problems of low sensitivity and poor specificity in feline coronavirus antigen detection were solved, achieving rapid detection with high sensitivity and specificity.

CN121698997BActive Publication Date: 2026-05-12BEIJING SUBENYUANHE BIOTECHNOLOGY CO LTD
4 Cites 0 Cited by

Patent Information

Application Number
CN202610209242.4
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2026-02-13
Publication Date
2026-05-12
Estimated Expiration
2046-02-13

AI Technical Summary

Technical Problem

Existing feline coronavirus antigen detection methods have low sensitivity and poor specificity, making them unsuitable for rapid screening at the grassroots level or on-site.

Method used

A monoclonal antibody combination, including monoclonal antibody 3C6 and monoclonal antibody 6H9, was developed for colloidal gold immunochromatographic detection to specifically recognize feline coronavirus NP protein. A colloidal gold immunochromatographic test strip was constructed.

Benefits of technology

It achieves high-sensitivity detection of FECV-NP and FIPV-NP, with a detection limit of 1 ng/mL, and no cross-reactivity with other feline pathogens, making it suitable for rapid, on-site detection.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader

Abstract

The application belongs to the technical field of biological detection, and particularly relates to a combination of monoclonal antibodies for detecting feline coronavirus NP protein and application thereof. The combination is composed of monoclonal antibodies 3C6 and 6H9, 3C6 is used as a coating antibody, and 6H9 is used for colloidal gold labeling, so that efficient and specific sandwich detection of feline coronavirus NP protein can be realized. The combination of monoclonal antibodies is applied to an immunodetection platform, and a rapid detection test strip or test card based on colloidal gold immunochromatography technology is constructed. The test card has high sensitivity to FECV-NP and FIPV-NP recombinant proteins, and has no cross reaction with other proteins, and is suitable for rapid and on-site detection.
Need to check novelty before this filing date? Find Prior Art